相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2015)
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Ricarda Herr et al.
CANCER RESEARCH (2015)
Epidemiology of Goblet Cell and Microvesicular Hyperplastic Polyps
Taha M. Qazi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
BRAF Mutation Predicts for Poor Outcomes After Metastasectomy in Patients With Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER (2014)
KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)
Harry H. Yoon et al.
CLINICAL CANCER RESEARCH (2014)
Excess of Proximal Microsatellite-Stable Colorectal Cancer in African Americans from a Multiethnic Study
Rosa M. Xicola et al.
CLINICAL CANCER RESEARCH (2014)
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
Wilson I. Gonsalves et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action
Dennis J. Ahnen et al.
MAYO CLINIC PROCEEDINGS (2014)
Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study
Jenny Brandstedt et al.
PLOS ONE (2014)
Interaction Between Age and Race Alters Predicted Survival in Colorectal Cancer
Uma R. Phatak et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Racial disparities in advanced-stage colorectal cancer survival
Kristin Wallace et al.
CANCER CAUSES & CONTROL (2013)
Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
Frank A. Sinicrope et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Brooke E. Sylvester et al.
CLINICAL CANCER RESEARCH (2012)
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2012)
Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
Patrick G. Gavin et al.
CLINICAL CANCER RESEARCH (2012)
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer A Randomized Trial
Steven R. Alberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Identification of a Poor-Prognosis BRAF-Mutant-Like Population of Patients With Colon Cancer
Vlad Popovici et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008
Anthony S. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Contribution of Behavioral Risk Factors and Obesity to Socioeconomic Differences in Colorectal Cancer Incidence
Chyke A. Doubeni et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials
Greg Yothers et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
Wendy De Roock et al.
LANCET ONCOLOGY (2011)
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
A. Farina-Sarasqueta et al.
ANNALS OF ONCOLOGY (2010)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Barbara Leggett et al.
GASTROENTEROLOGY (2010)
Cigarette Smoking and Colorectal Cancer Risk by Molecularly Defined Subtypes
David Limsui et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Racial/Ethnic Patterns of Uptake of Colorectal Screening, National Health Interview Survey 2000-2008
Vickie L. Shavers et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2010)
International Trends in Colorectal Cancer Incidence Rates
Melissa M. Center et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Alarming Colorectal Cancer Incidence Trends: A Case for Early Detection and Prevention
Asad Umar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum
Kristin Wallace et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
Krishan Kumar et al.
CLINICAL CANCER RESEARCH (2009)
Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial
Hanna K. Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer
Tara M. Breslin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A General Model for Testing Mediation and Moderation Effects
Amanda J. Fairchild et al.
PREVENTION SCIENCE (2009)
Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study
Hassan Brim et al.
MOLECULAR CANCER (2008)
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability
Frank A. Sinicrope et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer
Wade S. Samowitz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Ethnic differences in pharmacogenetically relevant genes
R. M. Engen et al.
CURRENT DRUG TARGETS (2006)
Colorectal cancer model of health disparities: Understanding mortality differences in minority populations
Blase N. Polite et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma
D Alexander et al.
CANCER (2004)
Progress in cancer screening practices in the United States - Results from the 2000 National Health Interview Survey
J Swan et al.
CANCER (2003)
Haplotype variation and linkage disequilibrium in 313 human genes
JC Stephens et al.
SCIENCE (2001)
分享论文
